Inhibitor Therapeutics, Inc. — All Filings
711 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10KSB
10KSB/A
10QSB
10QSB/A
15-12B
15-12B/A
25-NSE
3
4
4/A
424B1
424B3
5
8-A12B
8-K
8-K/A
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFR14A
DEFS14A
DFAN14A
EFFECT
NO ACT
NT 10-K
NT 10-Q
NTN 10Q
POS AM
PRE 14A
PRE 14C
PREM14A
PRER14A
PRES14A
REGDEX
RW
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001493152-26-012751 | Mar 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001493152-26-007821 | Feb 24, 2026 | — |
| 10-Q | 10-Q | 0001493152-25-022178 | Nov 13, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001493152-25-019381 | Oct 27, 2025 | Oct 24, 2025 |
| UPLOAD | — | 0000000000-25-009975 | Sep 15, 2025 | — |
| 10-Q | 10-Q | 0001641172-25-023465 | Aug 13, 2025 | Jun 30, 2025 |
| CORRESP | — | 0001641172-25-020608 | Jul 22, 2025 | — |
| UPLOAD | — | 0000000000-25-007569 | Jul 17, 2025 | — |
| 10-Q | 10-Q | 0001641172-25-010110 | May 14, 2025 | Mar 31, 2025 |
| 4 | — | 0001641172-25-003556 | Apr 10, 2025 | Apr 1, 2024 |
| 4 | — | 0001641172-25-003033 | Apr 7, 2025 | Apr 1, 2024 |
| 4 | — | 0001641172-25-003029 | Apr 7, 2025 | Apr 1, 2024 |
| 4 | — | 0001641172-25-003025 | Apr 7, 2025 | Apr 1, 2024 |
| 4 | — | 0001641172-25-003023 | Apr 7, 2025 | Apr 1, 2024 |
| 10-K | — | 0001641172-25-001190 | Mar 28, 2025 | Dec 31, 2024 |
| 5 | — | 0001493152-25-007628 | Feb 19, 2025 | Dec 31, 2024 |
| 5 | — | 0001493152-25-007626 | Feb 19, 2025 | Dec 31, 2024 |
| 10-Q | — | 0001493152-24-044473 | Nov 12, 2024 | Sep 30, 2024 |
| 10-Q | — | 0001493152-24-030381 | Aug 6, 2024 | Jun 30, 2024 |
| 4 | — | 0001493152-24-020171 | May 16, 2024 | Apr 1, 2024 |
| 4 | — | 0001493152-24-020169 | May 16, 2024 | Mar 16, 2024 |
| 4 | — | 0001493152-24-020173 | May 16, 2024 | Apr 1, 2024 |
| 4 | — | 0001493152-24-020172 | May 16, 2024 | Apr 1, 2024 |
| 4 | — | 0001493152-24-020170 | May 16, 2024 | Apr 1, 2024 |
| 10-Q | — | 0001493152-24-018805 | May 13, 2024 | Mar 31, 2024 |
| 10-K | — | 0001493152-24-011973 | Mar 29, 2024 | Dec 31, 2023 |
| 8-K | FORM 8-K | 0001193125-23-294696 | Dec 14, 2023 | Dec 12, 2023 |
| 10-Q | — | 0001493152-23-040351 | Nov 13, 2023 | Sep 30, 2023 |
| 8-K | 8-K | 0001193125-23-258156 | Oct 18, 2023 | Oct 13, 2023 |
| 4 | 4 | 0000950170-23-045043 | Aug 29, 2023 | Aug 18, 2023 |
| 3 | 3 | 0000950170-23-044993 | Aug 29, 2023 | May 5, 2023 |
| 8-K | 8-K | 0001193125-23-223590 | Aug 29, 2023 | Aug 23, 2023 |
| 10-Q | — | 0001493152-23-027740 | Aug 11, 2023 | Jun 30, 2023 |
| 8-K | — | 0001493152-23-019651 | May 31, 2023 | — |
| SC 13D | SC 13D | 0001193125-23-151524 | May 23, 2023 | — |
| SC 13G | SC 13G | 0001193125-23-151506 | May 23, 2023 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-23-013532 | May 22, 2023 | May 5, 2023 |
| SC 13G | SC 13G | 0001193125-23-147220 | May 18, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-23-013201 | May 17, 2023 | May 5, 2023 |
| 3 | FORM 3 SUBMISSION | 0000899243-23-013196 | May 17, 2023 | May 5, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-013195 | May 17, 2023 | May 5, 2023 |
| 10-Q | — | 0001493152-23-016967 | May 15, 2023 | Mar 31, 2023 |
| 10-K | — | 0001493152-23-010383 | Mar 31, 2023 | Dec 31, 2022 |
| 3 | FORM 3 SUBMISSION | 0000899243-22-039259 | Dec 22, 2022 | Dec 13, 2022 |
| 3 | FORM 3 SUBMISSION | 0000899243-22-039258 | Dec 22, 2022 | Dec 13, 2022 |
| 3 | FORM 3 SUBMISSION | 0000899243-22-039257 | Dec 22, 2022 | Dec 13, 2022 |
| 3 | FORM 3 SUBMISSION | 0000899243-22-039256 | Dec 22, 2022 | Dec 13, 2022 |
| 3 | FORM 3 SUBMISSION | 0000899243-22-039251 | Dec 22, 2022 | Dec 13, 2022 |
| 8-K | FORM 8-K | 0001193125-22-308415 | Dec 19, 2022 | Dec 13, 2022 |
| 10-Q | FORM 10-Q | 0001193125-22-284610 | Nov 14, 2022 | Sep 30, 2022 |